Researchers check for muscle side effects in cancer treatment
NCT ID NCT01248429
Summary
This study aimed to understand how often a muscle enzyme called CPK increases in cancer patients taking a common type of drug called tyrosine kinase inhibitors (TKIs). It involved 154 patients with solid tumors who had been on TKI treatment for at least a week. The researchers checked routine blood tests to measure CPK levels and see if higher levels were linked to muscle pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Bordeaux
Bordeaux, 33076, France
-
CHU Limoges
Limoges, 87042, France
-
CHU Robert Debré
Reims, 51092, France
-
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, 54511, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Eugène Marquis
Rennes, 35042, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre Henri Becquerel
Rouen, 76000, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Léon Bérard
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre Paul Papin
Angers, 49000, France
-
Centre René Huguenin
Saint-Cloud, 92211, France
-
Centre Val d'Aurelle
Montpellier, 34298, France
-
Hôpital Cochin - APHP
Paris, 75014, France
-
Hôpital Edouard Herriot
Lyon, 69003, France
-
Hôpital Henri Mondor - APHP
Créteil, 94010, France
-
Hôpital Jean Minjoz
Besançon, 25030, France
-
Hôpital Saint-Louis - APHP
Paris, 75010, France
-
Hôpital Tenon - APHP
Paris, 75020, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Régaud
Toulouse, 31052, France
-
Institut Curie
Paris, 75248, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut Jean Godinot
Reims, 51056, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut de Cancérologie de la Loire
Saint-Priest-en-Jarez, 42271, France
Conditions
Explore the condition pages connected to this study.